Dennis  Matheis net worth and biography

Dennis Matheis Biography and Net Worth

Director of DarioHealth

Dennis Matheis is President and Chief Executive Officer of Sentara Health. He has spent the past 30 years in senior leadership roles within the healthcare industry. Dennis previously served as Executive Vice President of Sentara Healthcare and President of Sentara Health Plans. Prior to joining Sentara, he spent 13 years in leadership roles at Anthem, Inc. Matheis serves on the Board of Directors of the Virginia Chamber of Commerce – Team Virginia and DarioHealth. He also serves on the Board of Directors and Executive Committee of America's Health Insurance Plans (AHIP). Matheis earned his B.S. in Accounting from the University of Kentucky and practiced as a Certified Public Accountant before entering the healthcare industry.

What is Dennis Matheis' net worth?

The estimated net worth of Dennis Matheis is at least $303.03 thousand as of July 23rd, 2026. Mr. Matheis owns 43,026 shares of DarioHealth stock worth more than $303,032 as of September 22nd. This net worth approximation does not reflect any other investments that Mr. Matheis may own. Learn More about Dennis Matheis' net worth.

How do I contact Dennis Matheis?

The corporate mailing address for Mr. Matheis and other DarioHealth executives is 322 W 57th ST. #33b, New York, NY, 10019. DarioHealth can also be reached via phone at +97247706377 and via email at [email protected]. Learn More on Dennis Matheis' contact information.

Has Dennis Matheis been buying or selling shares of DarioHealth?

Within the last three months, Dennis Matheis has bought $99,999.90 in DarioHealth stock. Most recently, on Thursday, July 23rd, Dennis Matheis bought 14,430 shares of DarioHealth stock. The stock was acquired at an average cost of $6.93 per share, with a total value of $99,999.90. Following the completion of the transaction, the director now directly owns 43,026 shares of the company's stock, valued at $298,170.18. Learn More on Dennis Matheis' trading history.

Who are DarioHealth's active insiders?

DarioHealth's insider roster includes Dror Bacher (COO), Oded Cohen (Insider), Dennis Matheis (Director), Dennis McGrath (Director), and Erez Raphael (CEO). Learn More on DarioHealth's active insiders.

Are insiders buying or selling shares of DarioHealth?

In the last year, DarioHealth insiders bought shares 1 times. They purchased a total of 14,430 shares worth more than $99,999.90. The most recent insider tranaction occured on July, 23rd when Director Dennis Matheis bought 14,430 shares worth more than $99,999.90. Insiders at DarioHealth own 3.5% of the company. Learn More about insider trades at DarioHealth.

Information on this page was last updated on 7/23/2026.

Dennis Matheis Insider Trading History at DarioHealth

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/23/2026Buy14,430$6.93$99,999.9043,026View SEC Filing Icon  
See Full Table

Dennis Matheis Buying and Selling Activity at DarioHealth

This chart shows Dennis Matheis's buying and selling at DarioHealth by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

DarioHealth Company Overview

DarioHealth logo
DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Evolve, a metabolic solution to address metabolic health needs, such as diabetes, pre-diabetes, hypertension, and weight management; Dario Move, which address most common musculoskeletal conditions; Dario Elevate, a behavioral health solution that optimizes access to evidence-based care; and Dario One, a full suite of chronic condition management solution; and Dario blood glucose monitoring systems. It also provides native devices, such as glucose meter, blood pressure cuff, digital scale, and biofeedback sensor device, as well as live coaching services. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.
Read More

Today's Range

Now: $6.99
Low: $6.95
High: $7.13

50 Day Range

MA: $7.17
Low: $6.53
High: $7.90

2 Week Range

Now: $6.99
Low: $5.84
High: $17.74

Volume

30,143 shs

Average Volume

28,214 shs

Market Capitalization

$68.50 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.12